Wear Red Day Quiz: How Much Do You Know About Heart Disease in Women?

Ahmad Masri, M.D., emphasizes that transthyretin amyloidosis (ATTR) is no longer a rare or untreatable disease, with more treatment options and clinical trials available now than ever, allowing patients to live longer and healthier lives.

After decades without a diagnosis, Allison Jamison advocates for earlier detection and treatment for homozygous familial hypercholesterolemia (HoFH).

Jesse Morse, M.D., discusses risk factors, signs and symptoms of DVT and why young athletes may be at increased risk for these events.

John A. Osborne, M.D., Ph.D., discusses how rapid treatment can prevent significant heart damage by restoring blood flow as quickly as possible.

Inozyme Pharma’s ongoing clinical trials show encouraging signs that its investigational treatment could prevent or reverse rickets in children with rare genetic disorders.

ENPP1 deficiency causes life-threatening calcification in newborns and severe bone deformities in children, making early diagnosis and treatment critical.

Michael Davidson, M.D., emphasizes the critical role of LDL cholesterol in cardiovascular disease, advocating for early and sustained treatment to prevent heart disease before complications arise.

A recent survey details the discordance between recommendations on aspirin use in older adults and real-world use of the long-time mainstay in risk management.

Study finds Amazon Pharmacy’s $5-per-month prescription program could save money and reduce days spent without medication for patients who participate.

A list of 5 important facts to understand about heart disease in the US based on a recent report from the American Heart Association.

Thomas Schermerhorn, M.D., highlights the safety and efficacy of transcarotid artery revascularization (TCAR) for patients with carotid stenosis.

Among older adults, better cardiorespiratory fitness was strongly linked to improved cognitive performance across multiple domains, including memory, processing speed and executive function.

Srihari S. Naidu, M.D., discusses the recent advancements in the treatment of obstructive hypertrophic cardiomyopathy (oHCM) that offer hope for better management and improved quality of life.

Christopher Kramer, M.D., underscores the importance of hydration, genetic screening and symptom monitoring for effective hypertrophic cardiomyopathy management.

Ahmad Masri, M.D., emphasizes that transthyretin amyloidosis (ATTR) is no longer a rare or untreatable disease, with more treatment options and clinical trials available now than ever, allowing patients to live longer and healthier lives.

After decades without a diagnosis, Allison Jamison advocates for earlier detection and treatment for homozygous familial hypercholesterolemia (HoFH).